BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26388155)

  • 1. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.
    Sun XX; Yu Q
    Acta Pharmacol Sin; 2015 Oct; 36(10):1219-27. PubMed ID: 26388155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
    Scanlon SE; Glazer PM
    DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes and consequences of genetic heterogeneity in cancer evolution.
    Burrell RA; McGranahan N; Bartek J; Swanton C
    Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 10. p53 Mutants Access Epigenetic Pathways to Promote Tumor Growth.
    Cancer Discov; 2015 Nov; 5(11):OF2. PubMed ID: 26424413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic sequencing for cancer diagnosis and therapy.
    Wang L; Wheeler DA
    Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribosyl)ation in carcinogenesis.
    Masutani M; Fujimori H
    Mol Aspects Med; 2013 Dec; 34(6):1202-16. PubMed ID: 23714734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.
    Sarris M; Nikolaou K; Talianidis I
    Oncogene; 2014 Mar; 33(10):1207-17. PubMed ID: 23503463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor genetic heterogeneity].
    Yang YL; Chu JY; Wang MR
    Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish as a cancer model.
    Feitsma H; Cuppen E
    Mol Cancer Res; 2008 May; 6(5):685-94. PubMed ID: 18505914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways in tumor progression: from discovery to functional understanding.
    Ali MA; Sjöblom T
    Mol Biosyst; 2009 Sep; 5(9):902-8. PubMed ID: 19668850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications.
    Kohnken R; Kodigepalli KM; Wu L
    Mol Cancer; 2015 Sep; 14():176. PubMed ID: 26416562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell profiling approaches to probing tumor heterogeneity.
    Khoo BL; Chaudhuri PK; Ramalingam N; Tan DS; Lim CT; Warkiani ME
    Int J Cancer; 2016 Jul; 139(2):243-55. PubMed ID: 26789729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.